Company profile LIFE

Atyr Pharma Inc
atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathie...s with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation Show More
Quarter analysis & expected interestLast update: November 09 2023 02:27:23.

After 34 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 58 days it will total up to 68.0.
aTyr Pharma expected interest is significantly higher compared to same quarter last year (+100.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 0
2019 48
inf% QoQ
51
6.2% QoQ
38
-25.5% QoQ
49
inf% YoY 28.9% QoQ
2020 73
52.1% YoY 49.0% QoQ
84
64.7% YoY 15.1% QoQ
19
-50.0% YoY -77.4% QoQ
65
32.7% YoY 242.1% QoQ
2021 200
174.0% YoY 207.7% QoQ
64
-23.8% YoY -68.0% QoQ
173
810.5% YoY 170.3% QoQ
43
-33.8% YoY -75.1% QoQ
2022 70
-65.0% YoY 62.8% QoQ
51
-20.3% YoY -27.1% QoQ
93
-46.2% YoY 82.4% QoQ
34
-20.9% YoY -63.4% QoQ
2023 50
-28.6% YoY 47.1% QoQ
60
17.6% YoY 20.0% QoQ
51
-45.2% YoY -15.0% QoQ
25
-26.5% YoY -51.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and aTyr Pharma search interestLast update: November 09 2023 02:27:23.
Correlation coefficient between keyword and revenue is -0.1
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 09 2023 02:27:24.

The average 5 years interest of aTyr Pharma was 5.14 per week.
The last year interest of aTyr Pharma compared to the last 5 years has changed by -22.18%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 29.87%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:44:10.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
aTyr Pharma news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019128
121
-5.5% QoQ
31
-74.4% QoQ
43
38.7% QoQ
2020 115
-10.2% YoY 167.4% QoQ
88
-27.3% YoY -23.5% QoQ
49
58.1% YoY -44.3% QoQ
116
169.8% YoY 136.7% QoQ
2021 133
15.7% YoY 14.7% QoQ
150
70.5% YoY 12.8% QoQ
145
195.9% YoY -3.3% QoQ
68
-41.4% YoY -53.1% QoQ
2022 64
-51.9% YoY -5.9% QoQ
108
-28.0% YoY 68.8% QoQ
0
-100.0% YoY -100.0% QoQ
51
-25.0% YoY inf% QoQ
2023 88
37.5% YoY 72.5% QoQ
172
59.3% YoY 95.5% QoQ
0
59.3% YoY -100.0% QoQ
215
321.6% YoY inf% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and aTyr Pharma news search interestLast update: February 09 2024 18:44:09.
Correlation coefficient between keyword and revenue is 0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:44:11.

The average 5 years interest of aTyr Pharma news was 7.22 per week.
The last year interest of aTyr Pharma news compared to the last 5 years has changed by 9.0%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 26.73%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:44:16.

After 39 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 52 days it will total up to 49.0.
efzofitimod expected interest is significantly lower compared to previous quarter (-77.6%) and same quarter last year (-83.0%).

YearQ1Q2Q3Q4
2019140
40
-71.4% QoQ
29
-27.5% QoQ
61
110.3% QoQ
2020 26
-81.4% YoY -57.4% QoQ
51
27.5% YoY 96.2% QoQ
72
148.3% YoY 41.2% QoQ
48
-21.3% YoY -33.3% QoQ
2021 47
80.8% YoY -2.1% QoQ
0
-100.0% YoY -100.0% QoQ
95
31.9% YoY inf% QoQ
172
258.3% YoY 81.1% QoQ
2022 121
157.4% YoY -29.7% QoQ
154
inf% YoY 27.3% QoQ
170
78.9% YoY 10.4% QoQ
63
-63.4% YoY -62.9% QoQ
2023 288
138.0% YoY 357.1% QoQ
0
-100.0% YoY -100.0% QoQ
212
24.7% YoY inf% QoQ
219
247.6% YoY 3.3% QoQ
2024 21
-92.7% YoY -90.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and efzofitimod search interestLast update: February 09 2024 18:44:16.
Correlation coefficient between keyword and revenue is -0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:44:17.

The average 5 years interest of efzofitimod was 7.77 per week.
The last year interest of efzofitimod compared to the last 5 years has changed by 52.25%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 107.91%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:44:22.

After 39 days of this quarter the interest is at 331.0. Based on that we can calculate that during remaining 52 days it will total up to 772.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019469
548
16.8% QoQ
747
36.3% QoQ
643
-13.9% QoQ
2020 803
71.2% YoY 24.9% QoQ
651
18.8% YoY -18.9% QoQ
665
-11.0% YoY 2.2% QoQ
592
-7.9% YoY -11.0% QoQ
2021 701
-12.7% YoY 18.4% QoQ
633
-2.8% YoY -9.7% QoQ
619
-6.9% YoY -2.2% QoQ
575
-2.9% YoY -7.1% QoQ
2022 654
-6.7% YoY 13.7% QoQ
636
0.5% YoY -2.8% QoQ
732
18.3% YoY 15.1% QoQ
680
18.3% YoY -7.1% QoQ
2023 860
31.5% YoY 26.5% QoQ
741
16.5% YoY -13.8% QoQ
768
4.9% YoY 3.6% QoQ
802
17.9% YoY 4.4% QoQ
2024 331
-61.5% YoY -58.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and pulmonary sarcoidosis search interestLast update: February 09 2024 18:44:21.
Correlation coefficient between keyword and revenue is 0.13
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:44:24.

The average 5 years interest of pulmonary sarcoidosis was 53.07 per week.
The last year interest of pulmonary sarcoidosis compared to the last 5 years has changed by 12.47%.
The interest for pulmonary sarcoidosis is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 13.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:44:30.

After 39 days of this quarter the interest is at 166.0. Based on that we can calculate that during remaining 52 days it will total up to 387.0.
interstitial lung diseases expected interest is significantly higher compared to previous quarter (+96.4%) and same quarter last year (+116.2%).

YearQ1Q2Q3Q4
201931
106
241.9% QoQ
139
31.1% QoQ
107
-23.0% QoQ
2020 175
464.5% YoY 63.6% QoQ
132
24.5% YoY -24.6% QoQ
144
3.6% YoY 9.1% QoQ
111
3.7% YoY -22.9% QoQ
2021 40
-77.1% YoY -64.0% QoQ
152
15.2% YoY 280.0% QoQ
171
18.8% YoY 12.5% QoQ
111
0.0% YoY -35.1% QoQ
2022 127
217.5% YoY 14.4% QoQ
160
5.3% YoY 26.0% QoQ
147
-14.0% YoY -8.1% QoQ
144
29.7% YoY -2.0% QoQ
2023 179
40.9% YoY 24.3% QoQ
114
-28.8% YoY -36.3% QoQ
179
21.8% YoY 57.0% QoQ
197
36.8% YoY 10.1% QoQ
2024 166
-7.3% YoY -15.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and interstitial lung diseases search interestLast update: February 09 2024 18:44:29.
Correlation coefficient between keyword and revenue is 0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:44:32.

The average 5 years interest of interstitial lung diseases was 10.85 per week.
The last year interest of interstitial lung diseases compared to the last 5 years has changed by 39.82%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 75.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 19:22:41.

After 39 days of this quarter the interest is at 267.0. Based on that we can calculate that during remaining 52 days it will total up to 623.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019306
412
34.6% QoQ
434
5.3% QoQ
380
-12.4% QoQ
2020 401
31.0% YoY 5.5% QoQ
417
1.2% YoY 4.0% QoQ
435
0.2% YoY 4.3% QoQ
471
23.9% YoY 8.3% QoQ
2021 435
8.5% YoY -7.6% QoQ
384
-7.9% YoY -11.7% QoQ
402
-7.6% YoY 4.7% QoQ
440
-6.6% YoY 9.5% QoQ
2022 643
47.8% YoY 46.1% QoQ
619
61.2% YoY -3.7% QoQ
517
28.6% YoY -16.5% QoQ
494
12.3% YoY -4.4% QoQ
2023 724
12.6% YoY 46.6% QoQ
643
3.9% YoY -11.2% QoQ
597
15.5% YoY -7.2% QoQ
585
18.4% YoY -2.0% QoQ
2024 267
-63.1% YoY -54.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and solid tumors search interestLast update: February 09 2024 19:22:40.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 19:22:42.

The average 5 years interest of solid tumors was 38.34 per week.
The last year interest of solid tumors compared to the last 5 years has changed by 25.04%.
The interest for solid tumors is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 46.02%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for atyr pharma clinical trial to provide analysis

Correlation between past revenue and atyr pharma clinical trial search interest

There is not enough data for atyr pharma clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for atyr pharma clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for kyoring pharmaceutical collaboration to provide analysis

Correlation between past revenue and kyoring pharmaceutical collaboration search interest

There is not enough data for kyoring pharmaceutical collaboration to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for kyoring pharmaceutical collaboration to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for aTyr Pharma stock price to provide analysis

Correlation between past revenue and aTyr Pharma stock price search interest

There is not enough data for aTyr Pharma stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for aTyr Pharma stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for LIFE
Earnings date: 2024-03-07 After close
Company name: Atyr Pharma Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T20:35:00Z

BusinessWire
Ethos Announces Early Lock-Up Release

2026-05-13T20:35:00Z

GlobeNewswire
Ethos Announces Early Lock-Up Release

2026-05-08T14:52:27Z

Analyst Upgrades
Barclays Maintains Overweight on Ethos Technologies, Raises Price Target to $27

2026-05-07T16:42:08Z

Analyst Upgrades
Citizens Maintains Market Outperform on Ethos Technologies, Raises Price Target to $27

2026-05-06T20:05:00Z

GlobeNewswire
Ethos Reports First Quarter Fiscal Year 2026 Financial Results

2026-05-05T13:07:00Z

GlobeNewswire
Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

2026-04-23T13:07:00Z

GlobeNewswire
Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

2026-04-02T20:05:00Z

GlobeNewswire
Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

2026-03-24T20:05:00Z

GlobeNewswire
Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

2026-02-26T21:06:05Z

GlobeNewswire
Ethos to Participate in The Citizens Technology Conference

2026-02-26T20:18:32Z

Analyst Upgrades
Citigroup Maintains Buy on Ethos Technologies, Raises Price Target to $16

2026-02-25T21:05:00Z

GlobeNewswire
Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

2026-02-24T11:13:54Z

Analyst Upgrades
Deutsche Bank Initiates Coverage On Ethos Technologies with Buy Rating, Announces Price Target of $23

2026-02-23T15:34:48Z

Analyst Upgrades
William Blair Initiates Coverage On Ethos Technologies with Outperform Rating

2026-02-23T15:33:04Z

Analyst Upgrades
Citigroup Initiates Coverage On Ethos Technologies with Buy Rating, Announces Price Target of $15